Literature DB >> 2869926

Pancreatic polypeptide in somatostatinoma.

D Pinsard, S Odent, D Chadenas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2869926     DOI： 10.1007/bf01311689

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

Authors:  E Ipp; R E Dobbs; V Harris; A Arimura; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Inhibitory effect of somatostatin on human pancreatic polypeptide secretion.

Authors:  J Marco; J A Hedo; M L Villanueva
Journal:  Life Sci       Date:  1977-09-15       Impact factor: 5.037

3.  [Endocrine pancreatic tumor secreting somatostatin and somatocrinin].

Authors:  D Chadenas; D Pinsard; D Melliere; J Trouillas; E S Zafrani; L Pradayrol; G Sassolas; Y Li; C Girod; J Aumaitre
Journal:  Presse Med       Date:  1985-12-07       Impact factor: 1.228

4.  Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas.

Authors:  J M Polak; S R Bloom; T E Adrian; P Heitz; M G Bryant; A G Pearse
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

5.  Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.

Authors:  D Rigaud; J P Accary; M Mignon; S Bonfils
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

6.  Mechanism of pancreatic polypeptide release in man.

Authors:  T E Adrian; H S Besterman; T J Cooke; S R Bloom; A J Barnes; R C Russell
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.